Cancer Commons Clinical Study uses advanced diagnostic tests to identify FDA-approved drugs that could work for your cancer type. Learn More Now

Cancer Research Insights & News
from Cancer Commons

Our expert team curates the latest in cancer care, from clinical trials to research updates, with insights from distinguished guests. We provide practical guidance to support decision-making at every stage.

Browse:

Using Real World Outcomes from “People Like Me” to Guide Cancer Treatment

One of the most powerful questions a cancer patient can ask is, “What worked for other people like me?” The company PotentiaMetrics gets to the heart of that question with Capire360, its externally validated survival analytics engine trained on 2.2 million real-world cancer cases, and Ardynn, its Personalized Shared Decision Making (PDSM) platform, with support delivered through independent certified patient advocates. Here, our Curious Dr. George asks Robert (Bobby) Palmer, MBA, founder and CEO of PotentiaMetrics, about how the 10-year-old company helps cancer patients, caregivers, and clinicians.

The Strong Helping Hand of Cancer Commons

Cancer is frequently accompanied by psychological distress and mental health challenges that are often neglected. Here, our Curious Dr. George asks Unsha Bakker, MSN, RN, OCN, CBCN, Cancer Commons Oncology Nurse Navigator for the Brain Cancer Support and Solutions Alliance (BCSSA), for her perspective on these issues—and how Cancer Commons can help.

Seeking Patients with Advanced Cancer for a New Clinical Study

Cancer Commons has launched a new clinical study that features drug sensitivity testing—laboratory testing of individual patients’ cancer cells to identify drugs that might work for them. Here, our Curious Dr. George asks Cancer Commons Director of Clinical Sciences Prajit Pillai, PhD, MBA, about the study.

Press Release: Cancer Commons Opens Enrollment in its N-of-1 Clinical Study, Enabling Personalized Off-Guideline Treatments for Advanced Cancer Patients at Any U.S. Hospital

The study is open to patients with any advanced cancer at any cancer hospital in the United States. Patients participate with their own oncologist, with no travel to a trial site required.

February 18, 2026

Morning Administration of Cancer Immunotherapy May Help Patients Live Twice as Long

Curious Dr. George chats with Cancer Commons scientist Amanda Nottke, PhD, to explore the latest insights on this intriguing possibility.

November 20, 2025

How Would a Mayo Clinic Oncologist Manage His Own Mantle Cell Lymphoma?

Curious Dr. George speaks with Mayo Clinic oncologist Javier Munoz, MD, MS, MBA.

October 30, 2025

Press Release: Brain Cancer Support and Solutions Alliance Launches Dedicated Nurse Navigator for Comprehensive Patient and Caregiver Assistance

September 26, 2025

How Would a Mayo Clinic Oncologist Manage His Own Acute Lymphocytic Leukemia?

Curious Dr. George poses that question to leukemia expert Mark R. Litzow, MD.

September 26, 2025

New Device from Lungpacer Medical Helps Patients with Advanced Cancer

Curious Dr. George interviews Doug, president and CEO of Lungpacer Medical, about this novel approach.

August 22, 2025

High-Energy Blue Light Produced by Ultrasound Activates a Promising New Treatment, Sonodynamic Therapy, to Destroy Cancer Cells: An Update

Curious Dr. George spoke with Stuart L. Marcus, MD, PhD, founder and Chief Science Officer of SonALAsense.

How Would a Mayo Clinic Oncologist Manage His Own Chronic Lymphocytic Leukemia?

Curious Dr. George (George Lundberg, MD) posed the question to Mayo Clinic oncologist Sameer A. Parikh, MBBS.

Finding the Best Drug for a Specific Cancer: an Update on Travera

Curious Dr. George catches up with Dennis Watson, Vice President of Business Development, to learn how Travera’s services have progressed.

How Would a Harvard Oncologist Manage His Own Chronic Lymphocytic Leukemia?

Curious Dr. George chats with Harvard oncologist Jon Arnason, MD.

Brad Power, Cancer Hacker—Redesigning the Patient Experience

Curious Dr. George talks with Brad about his work.

Raising AI Right: Prioritizing Humanity in Precision Medicine

Curious Dr. George talks with our Director of Technology, Michael Kramer, about how Cancer Commons can help shape the future of AI in oncology.

How Would an Expert Manage His Own Chronic Myelogenous Leukemia?

Curious Dr. George poses the question to expert oncologist Jerald. Radich, MD, MA, MS.

January 9, 2025

How an Expert Would Treat Her Own Metastatic Melanoma: an Update

Cancer patients often ask their doctors, “What would you do if you were me?” Here, our Curious Dr. George asks Stanford University School of Medicine oncologist Pauline Funchain, MD, how she would handle her own diagnosis of advanced melanoma.

January 2, 2025

A Better Way to Keep an Eye on Glioblastoma Tumors

Curious Dr. George chats with the company’s president and CEO, Michael Schmainda, about critical new advancements.

December 3, 2024

How an Expert Would Treat His Own Glioblastoma: An Update

When facing a new cancer diagnosis, some people ask their doctors, “What would you do if you were me?” Here, our Curious Dr. George asks Al Musella, DPM, how he would handle his own case of glioblastoma, a type of brain tumor. Dr. Musella is President of the Musella Foundation For Brain Tumor Research & Information, Inc., a partner of Cancer Commons.

November 8, 2024

Keep in the loop

Get useful cancer research insights and updates

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

We never share you data with third parties.